Hamilton Thorne adds Marc Robinson to its Board as Independent Director

– USA, MA – Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies, research, and cell biology markets, today announced the appointment of Marc Robinson to its Board as an independent director, effective January 19, 2021.

“We are delighted to have Marc join our Board of Directors,” said CEO, David Wolf. “As Hamilton Thorne continues to grow and evolve, it is important to add new voices and experience that will support our continued development over the next decade. We look forward to Marc’s advice and support as Hamilton Thorne continues growing its business.”

Diarmaid Douglas-Hamilton, a co-founder of Hamilton Thorne and its CTO, will retire from the Board of Directors but will continue to stay active with the Company.

Mr. Wolf continued, “I would like to personally thank and recognize Diarmaid for his significant and continued contributions to the Company’s growth. As a leader in our research and development group, he has a significant track record of innovation and has been the primary driver behind several Hamilton Thorne’s proprietary products.”

About Marc Robinson

Mr. Robinson currently serves as Managing Director, Investments at FAX Capital Corp. FAX Capital is a TSX listed holding company, focused on making long-term investments in high-quality public and private growth companies, and currently holds an 11.5% interest in Hamilton Thorne. Mr. Robinson is a seasoned executive with over 20 years of experience across various facets of the North American capital markets and has a demonstrable track record of successfully financing and advising high growth companies. Mr. Robinson has previously worked as a small-cap portfolio manager and was awarded the Lipper Award for Best 3-Year Performance, Canadian Focused Small/Mid Cap Equity in 2018. Previously, Mr. Robinson was an established equity research analyst at a leading Canadian small-cap focused investment dealer, where he also sat on the firm’s executive and risk committees, and worked as an investment banker at Merrill Lynch.

At FAX Capital, Mr. Robinson continues to drive its operational strategy and has directed investment decisions since the company’s inception. Mr. Robinson holds a Bachelor’s degree in Statistics from the University of Western Ontario and an Honours and Master’s degree in Business from the Richard Ivey School of Business.

About Hamilton Thorne Ltd.

Hamilton Thorne is a leading global provider of precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies, research, and cell biology markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed, Planer, and Embryotech Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thorne’s customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments.

For more information : http://www.hamiltonthorne.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team